ES8504754A1 - N-(3-trifluoromethyl phenyl)-N'-propargyl piperazine, method for its preparation and its use. - Google Patents

N-(3-trifluoromethyl phenyl)-N'-propargyl piperazine, method for its preparation and its use.

Info

Publication number
ES8504754A1
ES8504754A1 ES530073A ES530073A ES8504754A1 ES 8504754 A1 ES8504754 A1 ES 8504754A1 ES 530073 A ES530073 A ES 530073A ES 530073 A ES530073 A ES 530073A ES 8504754 A1 ES8504754 A1 ES 8504754A1
Authority
ES
Spain
Prior art keywords
preparation
trifluoromethyl phenyl
propargyl piperazine
propargyl
piperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES530073A
Other languages
Spanish (es)
Other versions
ES530073A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim GmbH
Original Assignee
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim GmbH filed Critical Boehringer Ingelheim GmbH
Publication of ES8504754A1 publication Critical patent/ES8504754A1/en
Publication of ES530073A0 publication Critical patent/ES530073A0/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The compound of the formula < IMAGE > and non-toxic, pharmacologically acceptable acid addition salts thereof. The compound as well as its salts are useful as analgesics.
ES530073A 1983-02-28 1984-02-27 PROCEDURE FOR PREPARING N- (3-TRIFLUOROMETIL FENIL) -N-PROPARGIL-PIPERAZINA. Granted ES530073A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833306964 DE3306964A1 (en) 1983-02-28 1983-02-28 NEW N-ARYLPIPERAZINE AND METHOD FOR THE PRODUCTION THEREOF

Publications (2)

Publication Number Publication Date
ES8504754A1 true ES8504754A1 (en) 1985-04-16
ES530073A0 ES530073A0 (en) 1985-04-16

Family

ID=6192038

Family Applications (7)

Application Number Title Priority Date Filing Date
ES530073A Granted ES530073A0 (en) 1983-02-28 1984-02-27 PROCEDURE FOR PREPARING N- (3-TRIFLUOROMETIL FENIL) -N-PROPARGIL-PIPERAZINA.
ES536411A Granted ES536411A0 (en) 1983-02-28 1984-10-01 PROCEDURE FOR PREPARING N- (3-TRIFLUOROMETHYLPHENYL) -N'-PROPARGIL-PIPERAZINE
ES536414A Expired ES8603445A1 (en) 1983-02-28 1984-10-01 N-(3-trifluoromethyl phenyl)-N'-propargyl piperazine, method for its preparation and its use.
ES536412A Granted ES536412A0 (en) 1983-02-28 1984-10-01 PROCEDURE FOR PREPARING N- (3-TRIFLUOROMETHYLPHENYL) -N'-PROPARGIL-PIPERAZINE
ES536416A Granted ES536416A0 (en) 1983-02-28 1984-10-01 PROCEDURE FOR PREPARING N- (3-TRIFLUOROMETHYLPHENYL) -N'-PROPARGIL-PIPERAZINE
ES536415A Expired ES8603446A1 (en) 1983-02-28 1984-10-01 N-(3-trifluoromethyl phenyl)-N'-propargyl piperazine, method for its preparation and its use.
ES536413A Granted ES536413A0 (en) 1983-02-28 1984-10-01 PROCEDURE FOR PREPARING N- (3-TRIFLUOROMETHYLPHENYL) -N'-PROPARGIL-PIPERAZINE

Family Applications After (6)

Application Number Title Priority Date Filing Date
ES536411A Granted ES536411A0 (en) 1983-02-28 1984-10-01 PROCEDURE FOR PREPARING N- (3-TRIFLUOROMETHYLPHENYL) -N'-PROPARGIL-PIPERAZINE
ES536414A Expired ES8603445A1 (en) 1983-02-28 1984-10-01 N-(3-trifluoromethyl phenyl)-N'-propargyl piperazine, method for its preparation and its use.
ES536412A Granted ES536412A0 (en) 1983-02-28 1984-10-01 PROCEDURE FOR PREPARING N- (3-TRIFLUOROMETHYLPHENYL) -N'-PROPARGIL-PIPERAZINE
ES536416A Granted ES536416A0 (en) 1983-02-28 1984-10-01 PROCEDURE FOR PREPARING N- (3-TRIFLUOROMETHYLPHENYL) -N'-PROPARGIL-PIPERAZINE
ES536415A Expired ES8603446A1 (en) 1983-02-28 1984-10-01 N-(3-trifluoromethyl phenyl)-N'-propargyl piperazine, method for its preparation and its use.
ES536413A Granted ES536413A0 (en) 1983-02-28 1984-10-01 PROCEDURE FOR PREPARING N- (3-TRIFLUOROMETHYLPHENYL) -N'-PROPARGIL-PIPERAZINE

Country Status (25)

Country Link
US (1) US4699910A (en)
EP (1) EP0117531B1 (en)
JP (1) JPS59210074A (en)
KR (1) KR910005413B1 (en)
AT (1) ATE22289T1 (en)
AU (1) AU562643B2 (en)
CA (1) CA1240327A (en)
CS (1) CS240997B2 (en)
DD (1) DD218096A5 (en)
DE (2) DE3306964A1 (en)
DK (1) DK158729C (en)
ES (7) ES530073A0 (en)
FI (1) FI77658C (en)
GB (1) GB2135997B (en)
GR (1) GR79822B (en)
HU (1) HU190546B (en)
IE (1) IE56938B1 (en)
IL (1) IL71068A (en)
NO (1) NO158803C (en)
NZ (1) NZ207289A (en)
PH (1) PH21982A (en)
PL (1) PL141275B1 (en)
PT (1) PT78155B (en)
SU (1) SU1223844A3 (en)
ZA (1) ZA841418B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03176457A (en) * 1989-12-04 1991-07-31 Nippon Paint Co Ltd Novel propargyl compound, its production and coating material containing the same compound
JPH05255089A (en) * 1991-12-18 1993-10-05 Sanwa Kagaku Kenkyusho Co Ltd Antiviral agent
US5661163A (en) 1995-06-07 1997-08-26 Merck & Co., Inc. Alpha-1a adrenergic receptor antagonists
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
EP2844346B1 (en) 2012-04-04 2020-01-01 Prilenia Neurotherapeutics Ltd. Pharmaceutical compositions for combination therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993899A (en) * 1958-03-31 1961-07-25 Miles Lab Acetylenically unsaturated piperazine derivatives
NL6607959A (en) * 1965-06-10 1966-12-12
DE1545561A1 (en) * 1965-08-23 1969-12-11 Acraf Process for the preparation of pharmacologically active N, N-disubstituted 1-aryl-3-aminopropines
FR2187311B1 (en) * 1972-06-02 1975-06-20 Bouchara Emile
GB1560271A (en) * 1977-01-14 1980-02-06 Joullie International Sa Therapeutically useful m-trifluoromethylphenylpiperazine derivatives
US4180574A (en) * 1978-12-26 1979-12-25 Abbott Laboratories Certain ovicidal piperazines
US4518712A (en) * 1980-06-30 1985-05-21 Taiho Pharmaceutical Company Limited Piperazine derivative and analgesic composition containing the same

Also Published As

Publication number Publication date
GR79822B (en) 1984-10-31
US4699910A (en) 1987-10-13
ES536414A0 (en) 1985-12-16
NO158803C (en) 1988-11-09
ES536415A0 (en) 1985-12-16
DK102084A (en) 1984-08-29
PL141275B1 (en) 1987-07-31
ATE22289T1 (en) 1986-10-15
PT78155B (en) 1986-07-17
GB2135997B (en) 1986-02-19
FI77658C (en) 1989-04-10
HU190546B (en) 1986-09-29
DK158729B (en) 1990-07-09
EP0117531B1 (en) 1986-09-17
AU2508584A (en) 1984-09-06
ES8603447A1 (en) 1985-12-16
IE840460L (en) 1984-08-28
ES8601174A1 (en) 1985-10-16
PL246418A1 (en) 1985-07-02
PH21982A (en) 1988-05-02
KR910005413B1 (en) 1991-07-29
DE3460733D1 (en) 1986-10-23
NZ207289A (en) 1986-07-11
JPS59210074A (en) 1984-11-28
JPH056545B2 (en) 1993-01-26
EP0117531A1 (en) 1984-09-05
ZA841418B (en) 1985-11-27
ES8603445A1 (en) 1985-12-16
PT78155A (en) 1984-03-01
DK102084D0 (en) 1984-02-24
AU562643B2 (en) 1987-06-18
ES8603444A1 (en) 1985-12-16
ES530073A0 (en) 1985-04-16
FI840743A (en) 1984-08-29
GB8405113D0 (en) 1984-04-04
ES8601173A1 (en) 1985-10-16
GB2135997A (en) 1984-09-12
IL71068A (en) 1988-05-31
CA1240327A (en) 1988-08-09
CS240997B2 (en) 1986-03-13
CS127484A2 (en) 1985-06-13
NO158803B (en) 1988-07-25
DE3306964A1 (en) 1984-09-06
NO840732L (en) 1984-08-29
IL71068A0 (en) 1984-05-31
IE56938B1 (en) 1992-02-12
ES8603446A1 (en) 1985-12-16
FI77658B (en) 1988-12-30
DD218096A5 (en) 1985-01-30
ES536411A0 (en) 1985-10-16
ES536412A0 (en) 1985-10-16
FI840743A0 (en) 1984-02-23
ES536413A0 (en) 1985-12-16
DK158729C (en) 1990-11-19
KR840007875A (en) 1984-12-11
SU1223844A3 (en) 1986-04-07
ES536416A0 (en) 1985-12-16

Similar Documents

Publication Publication Date Title
ES8303409A1 (en) N-(4-Aminobenzoyl)-N&#39;-benzylbispidine, its preparation and pharmaceutical compositions containing it.
ES8308543A1 (en) Substituted 2-phenyl-2-(pyridyloxy)-ethyl amines and isosteric compounds, process for their preparation and use.
ES8504754A1 (en) N-(3-trifluoromethyl phenyl)-N&#39;-propargyl piperazine, method for its preparation and its use.
GR79508B (en)
ES2001389A6 (en) Substituted toluidines, process for their preparation, pharmaceutical compositions containing them and their use as gastric secretion inhibitors.
ES8506641A1 (en) 1-Acetonyl-2-(phenylimino)-imidazolidines, their addition salts, their pharmaceutical compositions and their preparation.
ES8205219A1 (en) Hydrouracil compounds.
ES8106147A1 (en) 1,2,4-Triazole-3-thiols as antisecretory agents
IL71987A (en) N-(beta-fluoroethyl)nortropine,its preparation and use in preparation of the corresponding 3-alpha-benzilate
JPS57200397A (en) Novel aldohexopyranose-, aldopentopyranose-, or and medicament composition comprising it aldopentofuranose- nitrosourea compound, its preparation
ES489925A1 (en) (3-Methyl-2-butenyl)propanedioic acid mono (1,2-diphenylhydrazide) and salts thereof
DE3467297D1 (en) Benzobicyclononane amino derivatives with anticonvulsive properties
AU2138988A (en) Amine salts of alkane-1,n-dicarboxylic acid mono- (2-sulfato-ethyl)amides
ES8706653A1 (en) Pharmacologically active propionylanilides.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203